OXTELLAR XR Trademark

Trademark Overview

On Tuesday, September 18, 2012, a trademark application was filed for OXTELLAR XR with the United States Patent and Trademark Office. The USPTO has given the OXTELLAR XR trademark a serial number of 85732114. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, April 8, 2024. This trademark is owned by Supernus Pharmaceuticals, Inc.. The OXTELLAR XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
oxtellar xr

General Information

Serial Number85732114
Word MarkOXTELLAR XR
Filing DateTuesday, September 18, 2012
Status800 - REGISTERED AND RENEWED
Status DateMonday, April 8, 2024
Registration Number4441262
Registration DateTuesday, November 26, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 21, 2012
Primary Code005
First Use Anywhere DateThursday, February 28, 2013
First Use In Commerce DateThursday, February 28, 2013

Trademark Owner History

Party NameSupernus Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, September 21, 2012NEW APPLICATION ENTERED
Friday, September 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 14, 2013ASSIGNED TO EXAMINER
Friday, January 18, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, January 18, 2013EXAMINERS AMENDMENT E-MAILED
Friday, January 18, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 18, 2013EXAMINER'S AMENDMENT ENTERED
Friday, January 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 31, 2013ASSIGNED TO LIE
Friday, February 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2013PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 13, 2013TEAS STATEMENT OF USE RECEIVED
Friday, September 13, 2013USE AMENDMENT FILED
Friday, October 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, October 19, 2013STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 22, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 24, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, October 25, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 26, 2013REGISTERED-PRINCIPAL REGISTER
Monday, November 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 26, 2019TEAS SECTION 8 & 15 RECEIVED
Saturday, January 18, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, January 18, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, January 18, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 26, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, November 27, 2023TEAS SECTION 8 & 9 RECEIVED
Monday, April 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 8, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 8, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, April 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

oxtellar diseases disorders system nervous preparations psychiatric neurological substances peripheral central